Thera Plus Original Strength Triple Antibiotic

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Thera Plus Original Strength Triple Antibiotic
Generic name
BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE
Manufacturer
Fourstar Group USA, Inc
Product type
HUMAN OTC DRUG
SPL set ID
2f916502-4daf-4cb9-a638-f37bb96c8077
SPL ID
44fbe805-2f02-fcac-e063-6394a90ad403
Version
1
Effective date
2025-12-02
Source export date
2026-11-06
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/4dafeb36642dffb72e2138939a956de402f722ea8c14c08cd87068efd3669f01/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 06:47:34
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use • if you are allergic to any of the ingredients in this product • in contact with the eyes or mucous membranes • over large areas of the body • longer than 1 week unless directed by a doctor When using this product avoid contact with eyes Ask a doctor before use if you have • deep or puncture wounds • animal bites • serious burns Stop use and ask a doctor if • symptoms last for more than 7 days • the conditions persists or gets worse • symptoms clear up and the occur again within a few days • a rash or other allergic reaction occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.